Juske, MB - financials and debts

Company age: 2 y. 5 mo.

Update

Juske - Company finances

EUR
2024
From: 2024-04-30
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 28,851 62,181
Profit before tax 5,777 5,902
Net profit 5,431 5,505
Equity 5,431 10,936
Liabilities 3,762 9,582
Non-current assets 0 0
Current assets 9,193 20,518
Total assets 9,193 20,518
Taxes paid
STI taxes - 3,974
Financial indicators
Revenue change y/y - +115.5%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 59.1% 26.8%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 100.0% 50.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 18.8% 8.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 20.0% 9.5%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.7 0.9
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Juske - Social security debts

The company had no debts to Sodra

Juske - VMI tax arrears

From To Overdue, €
2026-08-25 2026-08-26 2.52
2026-08-12 2026-08-24 656.27
2026-08-09 2026-08-11 655.73
2026-08-02 2026-08-08 654.47
2026-07-26 2026-08-01 40.72
2026-07-02 2026-07-25 1.32
2026-06-19 2026-07-01 603.6
2026-06-03 2026-06-18 205.26
2026-06-02 2026-06-02 221.34
2026-06-01 2026-06-01 224.34
2026-05-31 2026-05-31 223.74
2026-05-22 2026-05-30 208.33
2026-05-20 2026-05-21 571.55
2026-05-19 2026-05-19 571.55
2026-05-18 2026-05-18 571.55
2026-05-17 2026-05-17 571.55
2026-05-14 2026-05-16 571.55
2026-05-13 2026-05-13 571.87
2026-05-12 2026-05-12 571.87
2026-05-11 2026-05-11 571.87
2026-05-10 2026-05-10 571.87
2026-05-08 2026-05-09 571.83
2026-05-06 2026-05-07 571.83
2026-05-03 2026-05-05 710.38
2026-05-01 2026-05-02 707.23
2026-04-30 2026-04-30 707.15
2026-04-28 2026-04-29 568.4
2026-04-27 2026-04-27 380.06
2026-04-26 2026-04-26 380.06
2026-04-24 2026-04-25 380.06
2026-04-23 2026-04-23 380.06
2026-04-22 2026-04-22 380.06
2026-04-20 2026-04-21 380.06
2026-04-17 2026-04-19 380.06
2026-04-15 2026-04-16 380.06
2026-04-14 2026-04-14 380.06
2026-04-13 2026-04-13 380.06
2026-04-12 2026-04-12 380.06
2026-04-10 2026-04-11 380.06
2026-04-09 2026-04-09 380.06
2026-04-08 2026-04-08 380.06
2026-04-02 2026-04-07 378.21
2026-04-01 2026-04-01 378.21
2026-03-27 2026-03-31 189.38
2026-03-24 2026-03-26 189.38
2026-03-20 2026-03-23 194.78
2026-03-19 2026-03-19 3.19
2026-03-18 2026-03-18 3.19
2026-03-16 2026-03-17 3.19
2026-03-13 2026-03-15 3.19
2026-03-12 2026-03-12 2.54
2026-03-11 2026-03-11 2.54
2026-03-08 2026-03-10 696.64
2026-03-02 2026-03-07 824.8
2026-02-27 2026-03-01 0.0
2026-02-21 2026-02-26 0.0
2026-02-18 2026-02-20 0.0
2026-02-03 2026-02-17 74.1
2026-02-01 2026-02-02 74.08
2026-01-31 2026-01-31 74.08
2026-01-30 2026-01-30 74.02
2026-01-29 2026-01-29 74.02
2026-01-27 2026-01-28 0.0
2026-01-23 2026-01-26 0.0
2026-01-22 2026-01-22 0.0
2026-01-20 2026-01-21 0.0
2026-01-19 2026-01-19 0.0
2026-01-18 2026-01-18 0.0
2026-01-16 2026-01-17 191.17
2026-01-15 2026-01-15 191.35
2026-01-14 2026-01-14 191.35
2026-01-13 2026-01-13 191.35
2026-01-12 2026-01-12 191.35
2026-01-09 2026-01-11 191.35
2026-01-08 2026-01-08 191.35
2026-01-05 2026-01-07 191.35
2026-01-03 2026-01-04 552.38
2026-01-02 2026-01-02 552.28
2026-01-01 2026-01-01 552.28
2025-12-30 2025-12-31 191.1
2025-12-29 2025-12-29 191.1
2025-12-28 2025-12-28 191.1
2025-12-26 2025-12-27 1.01
2025-12-25 2025-12-25 1.01
2025-12-24 2025-12-24 1.01
2025-12-23 2025-12-23 1.01
2025-12-22 2025-12-22 1.01
2025-12-19 2025-12-21 1.01
2025-12-18 2025-12-18 1.01
2025-12-17 2025-12-17 1.01
2025-12-15 2025-12-16 1.01
2025-12-12 2025-12-14 1.01
2025-12-11 2025-12-11 1.01
2025-12-09 2025-12-10 1.01
2025-12-08 2025-12-08 1.01
2025-12-05 2025-12-07 1.01
2025-12-03 2025-12-04 1.01
2025-12-02 2025-12-02 1.01
2025-11-30 2025-12-01 1.01
2025-11-28 2025-11-29 0.98
2025-11-27 2025-11-27 121.55
2025-11-25 2025-11-26 0.0
2025-11-24 2025-11-24 0.0
2025-11-21 2025-11-23 0.0
2025-11-20 2025-11-20 0.0
2025-11-18 2025-11-19 983.97
2025-11-14 2025-11-17 984.22
2025-11-12 2025-11-13 939.99
2025-11-07 2025-11-07 0.37
2025-11-02 2025-11-02 1363.15
2025-10-30 2025-11-01 0.52
2025-10-09 2025-10-29 0.48
2025-09-16 2025-09-30 0.24
2025-06-19 2025-07-20 0.24
2025-06-18 2025-06-18 870.14
2025-05-17 2025-06-02 4.0

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Juske, MB (company code 306737854) is a Lithuanian small partnership engaged in the retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €62.2K and net profit of €5.5K, compared with €28.9K revenue and €5.4K net profit in 2024. Revenue more than doubled year on year, while profitability remained positive but the net margin eased from 18.8% in 2024 to 8.9% in 2025. This indicates that the business expanded its sales base faster than profits increased. At the end of 2025, total assets stood at €20.5K, supported by equity of €10.9K and liabilities of €9.6K. The equity ratio was 53.3% and debt-to-equity was 0.88, showing a balanced financing structure. Asset turnover reached 3.03x, reflecting efficient use of the asset base. Return on equity was 50.3% and return on assets 26.8% in 2025, both supported by the company’s relatively small balance sheet.